Breaks Categories: News

FridayOct 09, 2020 12:11 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA Co-Founder Patrick Lin’s recent stock purchase at near current price. The article reads, “Potential Processa Pharmaceuticals Inc. (NASDAQ: PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just…

Continue Reading

FridayOct 09, 2020 11:42 am

NetworkNewsBreaks – Cardiff Oncology Inc. (NASDAQ: CRDF) Announces Pricing of Underwritten Public Offering

Cardiff Oncology (NASDAQ: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, recently announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $13.50 per share. Cardiff Oncology anticipates receipt of approximately $88 million in gross proceeds from the offering, which is expected to close on or about October 2, 2020, subject to the satisfaction of customary conditions. The company has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares at…

Continue Reading

FridayOct 09, 2020 11:10 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Begins Manufacturing of Lead Drug Candidate in Europe

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A. ("BSP"), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (“GBM”). GBM is an aggressive form of brain cancer currently considered incurable. “Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” CNS Pharmaceuticals CEO John Climaco said in the news release. “With the manufacturing of our…

Continue Reading

FridayOct 09, 2020 10:29 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products…

Continue Reading

FridayOct 09, 2020 9:53 am

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Featured as Top Performer in Industry Report

Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., on Thursday announced that it is featured in a recent industry report (https://nnw.fm/XhXSO) by Transformation Capital, an investment banking and business development firm. According to the update, Sharing Services, which operates two primary subsidiaries — Elepreneurs U.S. LLC, a direct-selling company, and Elevacity(R) U.S. LLC, a products company — is listed by Transformation Capital as one of the fastest-growing small-cap companies in the space. The report reads, “SHRG, the parent company of Elepreneurs, a health and wellness beverage company focused on nootropics, has been the top performer amongst all stocks in…

Continue Reading

ThursdayOct 08, 2020 2:00 pm

NetworkNewsBreaks – Mission Produce Inc. (NASDAQ: AVO) Closes $96M IPO

Mission Produce (NASDAQ: AVO) has closed its initial public offering (“IPO”) of 8,000,000 shares of its common stock, which consisted of 6,250,000 shares offered by Mission Produce and 1,750,000 shares offered by certain selling stockholders. Closing of the IPO resulted in approximately $96 million in gross proceeds, with each of the shares sold at the public offering price of $12.00. Mission Produce has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock. The shares began trading on the NASDAQ Global Select Market under the symbol “AVO” on Oct. 1, 2020. ROTH Capital…

Continue Reading

ThursdayOct 08, 2020 1:35 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Board Appointment of Seasoned Retail Veteran

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of directors, effective Oct. 8, 2020. Lazaran will serve on the company’s audit and compensation committees. Simultaneous to the appointment, Bruce Leitch has decided to step down from the company's board of directors to focus on other business endeavors. “On behalf of the board, we are delighted to welcome Frank Lazaran as a full-time member of The Alkaline Water Company's Board of Directors,” WTER Chairman of…

Continue Reading

ThursdayOct 08, 2020 12:46 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Appoints Proven Exec to Accelerate Commercialization of DRIVRZ

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced the addition of Steve Waller, one of the U.S. automotive retail and banking sectors' proven leaders, to its advisory team. Waller brings unique C-suite experience with Fortune 100, 300 and 500 companies to accelerate PowerBand’s commercialization of its virtual platform - DRIVRZ - which enables the quick and efficient online buying, selling, leasing, trading and financing of vehicles. "Steve is a remarkable executive and brings great strategic and operational expertise to PowerBand's mission to transform the automotive retail experience," PowerBand CEO Kelly Jennings…

Continue Reading

ThursdayOct 08, 2020 12:22 pm

NetworkNewsBreaks – CB Scientific Inc. (CBSC) Announces Thailand Launch of My-Cardia ECG Product Line, Services

CB Scientific (OTC: CBSC), engaged in providing innovative products and services for the ambulatory noninvasive cardiac monitoring space, today announced the targeted start of cardiac lab services operations in the country of Thailand through CBSC’s exclusive authorized distributor, Mango Wellness Co. Ltd. (“MWC”) and My Cardia Thailand Co. Ltd. (“MCT”), beginning Oct. 29, 2020. Under the agreement, MWC and MCT will be the exclusive distributor for CBSC’s proprietary FDA and CE-cleared EKG my-Cam Cardiac Event Monitor, the interactive cloud-based My-Cardia acquisition software, and the associated smartphone apps for both iOS and Android platforms in Thailand. The My-Cardia product line is…

Continue Reading

ThursdayOct 08, 2020 11:40 am

NetworkNewsBreaks – Loop Industries Inc. (NASDAQ: LOOP) Secures $26.6M in Underwritten Public Offering

Loop Industries (NASDAQ: LOOP), a leading innovator in sustainable plastics technology, has closed an underwritten public offering of 2,087,000 shares of its common stock, including 207,000 additional shares pursuant to the partial exercise of the over-allotment option granted to the underwriters. Loop Industries secured approximately $26.6 million in gross proceeds, with each of the shares sold at the public offering price of $12.75. The company intends to use the proceeds for working capital and general corporate purposes, including continued investment in research and development for further innovation and funding ongoing operations. Roth Capital Partners acted as sole manager for the…

Continue Reading